Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neuroma, Acoustic × Fluorescein × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 2 Thyroid Diseases 1 Paget Disease, Extramammary 1 Neuroma, Acoustic 1 Glioma 1 Adenolymphoma 1

Interventions

Everolimus 2 Bevacizumab 2 tozuleristide 1 neratinib 1 icotinib 1 brigatinib 1 Sirolimus 1 Mn-PyC3A 1 Lapatinib 1 Fluoresceins 1 Fluorescein 1 Endostatins 1 Axitinib 1 Aspirin 1 AZD 6244 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04351373 2023-08-01

Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560

Mayo Clinic

Phase 2 Completed

12 enrolled 11 charts

Neuroma, Acoustic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡